Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
The Macmillan Support and Information Service celebrates its developments and achievements since opening ten years ago.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. In some cases, the tumour spreads into the surrounding areas.
-
This page is for patients who have been referred on a suspected cancer pathway.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
A national study with initial results shows steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients.
-
The Secretary of State for Health and Social Care, The Rt. Hon. Sajid Javid MP visited the National Hospital for Neurology and Neurosurgery (NHNN), earlier this week (Wednesday 4 May 2022).
-
Robot-assisted surgery used to perform bladder cancer removal and reconstruction enables patients to recover far more quickly and spend significantly less time in hospital, concludes a trial led by UCLH, UCL and the University of Sheffield.
File results
-
FOI/2024/0635 - Patient incidences/ injuries due to chiropractic treatment
-
FOI/2024/0634 - Private Finance Initiative (PFI) and Private Finance 2 (PF2) projects repayments and debt
-
FOI/2024/0627 - E-signature vendor supplier and cost
-
FOI/2024/0210 - Clear identification of registered nurses/ job title on badges
-
FOI/2024/0091 - Primary HIFU PA procedures/ salvage HIFU procedures HEAT registry
-
FOI/2024/0475 - Prophylactic hydrocortisone neonatal deaths in 2023
-
FOI/2024/0554 - Robotic Process Automation (RPA) Programme
-
FOI/2024/0541 - Healthcare-associated infections (HAIs) 2022-2024
-
FOI/2024/0537 - SHO doctor shifts covered by physician associates December 2023-May 2024
-
FOI/2024/0548 - Patient transport services, providers/ charges